Shine-on Biomedical Co., Ltd.

This study tests a new drug called SOA101, a special antibody that grabs onto cancer cells and helps the immune system attack them. It is for people with advanced solid tumors (like lung, ovarian, or breast cancer) who have no other good treatment options. The trial will first fi…

This early-stage trial tests a new drug called SOB100, which uses tiny particles called exosomes to deliver a targeted therapy. The study involves 15 healthy adults and aims to check if the drug is safe and tolerable. It is a dose-escalation study, meaning participants receive in…